TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Pharmavizer AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
6
|
12
|
59 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-1
|
-1
|
48 |
| EBITDA |
-1
|
-1
|
48 |
| Total assets |
68
|
82
|
93 |
| Current assets |
39
|
53
|
62 |
| Current liabilities |
7
|
19
|
21 |
| Equity capital |
57
|
58
|
66 |
| - share capital |
5
|
4
|
5 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
83.8%
|
70.7%
|
71.0% |
| Turnover per employee |
6
|
12
|
59 |
| Profit as a percentage of turnover |
-16.7%
|
-8.3%
|
81.4% |
| Return on assets (ROA) |
-1.5%
|
-1.2%
|
51.6% |
| Current ratio |
557.1%
|
278.9%
|
295.2% |
| Return on equity (ROE) |
-1.8%
|
-1.7%
|
72.7% |
| Change turnover |
-6
|
-43
|
31 |
| Change turnover % |
-50%
|
-78%
|
113% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.